Elevation Oncology Highlights First-in-Human Phase 1 SYSA180

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Related Keywords

China , Chicago , Illinois , United States , American , Chunlei Li , Valerie Malyvanh Jansen , Yakun Wang , Elevation Oncology Inc , Corporate Communications Investor Relations , American Society Of Clinical Oncology , Prnewswire Elevation Oncology Inc , Nasdaq , Exchange Commission , Group Limited , Drug Administration , American Society , Clinical Oncology , Chief Medical Officer , Elevation Oncology , Chief Scientific Officer , Poster Discussion , Molecularly Targeted Agents , Session Date , Discussion Date , Investigational New Drug , Private Securities Litigation Reform Act , Oncology Investor , Corporate Communications ,